Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visionflex GroupASX:VFX -9.09% 3-Year EBITDA Growth Rate is 54.10% as of Dec. 2025, which is 77% above its 10-year median of 30.65. The stock has 6 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Visionflex Group ranks better than 92.37% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 54.10% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 44.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 30.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Visionflex Group was 58.40% per year. The lowest was 5.60% per year. And the median was 30.65% per year.
Visionflex Group (ASX:VFX) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Visionflex Group 3-Year EBITDA Growth Rate Related Terms
ASX:VFX vs VEEV, BTSG, HQY: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Visionflex Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visionflex Group 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Visionflex Group's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Visionflex Group's 3-Year EBITDA Growth Rate falls into.
Visionflex Group 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 54.10% mean?
Visionflex Group (ASX:VFX) has a 3-Year EBITDA Growth Rate of 54.10% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Visionflex Group and its competitors. This is 77% above median its historical median of 30.65. Over the past decade, Visionflex Group's 3-Year EBITDA Growth Rate has ranged from 5.60 to 58.40. According to the industry distribution chart, Visionflex Group ranks #40 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 7.6%.
Is Visionflex Group's 3-Year EBITDA Growth Rate too high?
Visionflex Group's current 3-Year EBITDA Growth Rate of 54.10% is 77% above median its 10-year median of 30.65. Over the past 10 years, this metric has ranged from a low of 5.60 to a high of 58.40. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Visionflex Group's value of 54.10% is 430.4% above this industry median. Based on the distribution chart, Visionflex Group ranks #40 out of 524 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Visionflex Group's 3-Year EBITDA Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Visionflex Group ranks #40 out of 524 companies for 3-Year EBITDA Growth Rate. This places Visionflex Group in the top 8% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.20. Visionflex Group's value of 54.10% is 430.4% above this benchmark. Historically, Visionflex Group's own 3-Year EBITDA Growth Rate has ranged from 5.60 to 58.40 over the past decade. While the company's 10-year median is 30.65 vs. the industry median of 10.20, Visionflex Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visionflex Group's current 3-Year EBITDA Growth Rate of 54.10% is 430.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Visionflex Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visionflex Group's current 3-Year EBITDA Growth Rate is 54.10%, which is 77% above median its own 10-year median of 30.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visionflex Group stock overvalued right now?
Based on GuruFocus' analysis, Visionflex Group (ASX:VFX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.07, compared to a current price of A$0.05 — trading 28.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 54.10%, which is 77% above median its 10-year median of 30.65 and 430.4% above the Healthcare Providers & Services industry median of 10.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Visionflex Group (ASX:VFX), the current 3-Year EBITDA Growth Rate is 54.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Visionflex Group Ltd is an online health portal group. The company is engaged in the provision of health care and corporate online search and appointment booking services. The group has three operating segments: Visionflex, Legacy 1ST Group Booking Businesses, and Corporate head office. The company generates the majority of its revenue from the Visionflex segment, which is engaged in Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. Legacy 1ST Group Businesses is engaged in the provision of healthcare and corporate online search and appointment booking services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VFX has been successfully added to your 
